ALPHA TEKNOVA, INC. Diluted Shares Outstanding (Weighted Average)
ALPHA TEKNOVA, INC. (TKNO) reported Diluted Shares Outstanding (Weighted Average) of 53.63 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 53.63M shares, a 0.35% increase year-over-year.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 53.61M shares, a 0.35% increase year-over-year.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 53.54M shares, a 0.23% increase year-over-year.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 53.52M shares, a 3.27% increase year-over-year.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 53.48M shares, a 14.41% increase from fiscal 2024.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 46.75M shares, a 46.91% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 31.82M shares, a 13.30% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 28.08M shares, a 74.57% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 53.63M shares 10-Q · filed 2026-08-06 | 53.61M shares 10-Q · filed 2026-08-06 | 53.60M shares derived: average of 3 quarters · filed 2026-08-06 | 53.58M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 53.61M shares 10-Q · filed 2026-05-07 | 53.58M shares derived: average of 2 quarters · filed 2026-05-07 | 53.56M shares derived: average of 3 quarters · filed 2026-05-07 | 53.53M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 53.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 53.53M shares derived: average of 2 quarters · filed 2026-03-02 | 53.50M shares derived: average of 3 quarters · filed 2026-08-06 | 53.48M shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 53.52M shares 10-Q · filed 2025-11-07 | 53.48M shares derived: average of 2 quarters · filed 2026-08-06 | 53.46M shares 10-Q · filed 2025-11-07 | 53.45M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 53.45M shares 10-Q · filed 2026-08-06 | 53.44M shares 10-Q · filed 2026-08-06 | 53.43M shares derived: average of 3 quarters · filed 2026-08-06 | 53.03M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 53.42M shares 10-Q · filed 2026-05-07 | 53.42M shares derived: average of 2 quarters · filed 2026-05-07 | 52.89M shares derived: average of 3 quarters · filed 2026-05-07 | 49.88M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 53.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 52.62M shares derived: average of 2 quarters · filed 2026-03-02 | 48.70M shares derived: average of 3 quarters · filed 2026-03-02 | 46.75M shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 51.82M shares 10-Q · filed 2025-11-07 | 46.34M shares derived: average of 2 quarters · filed 2025-11-07 | 44.52M shares 10-Q · filed 2025-11-07 | 43.58M shares derived: average of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | 40.85M shares 10-Q · filed 2025-08-08 | 40.83M shares 10-Q · filed 2025-08-08 | 40.84M shares derived: average of 3 quarters · filed 2025-08-08 | 38.12M shares derived: average of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | 40.80M shares 10-Q · filed 2025-05-09 | 40.83M shares derived: average of 2 quarters · filed 2025-05-09 | 37.20M shares derived: average of 3 quarters · filed 2025-05-09 | 34.97M shares derived: average of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | 40.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 35.40M shares derived: average of 2 quarters · filed 2025-03-07 | 33.03M shares derived: average of 3 quarters · filed 2025-03-07 | 31.82M shares 10-K · filed 2025-03-07 |
| 2023-09-30 | 29.96M shares 10-Q · filed 2024-11-08 | 29.11M shares derived: average of 2 quarters · filed 2024-11-08 | 28.81M shares 10-Q · filed 2024-11-08 | 28.64M shares derived: average of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | 28.27M shares 10-Q · filed 2024-08-13 | 28.23M shares 10-Q · filed 2024-08-13 | 28.20M shares derived: average of 3 quarters · filed 2024-08-13 | 28.17M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 28.18M shares 10-Q · filed 2024-05-13 | 28.17M shares derived: average of 2 quarters · filed 2024-05-13 | 28.14M shares derived: average of 3 quarters · filed 2024-05-13 | 28.12M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 28.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 28.12M shares derived: average of 2 quarters · filed 2024-03-27 | 28.10M shares derived: average of 3 quarters · filed 2024-03-27 | 28.08M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 28.09M shares 10-Q · filed 2023-11-13 | 28.07M shares derived: average of 2 quarters · filed 2023-11-13 | 28.06M shares 10-Q · filed 2023-11-13 | 28.08M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 28.06M shares 10-Q · filed 2023-08-11 | 28.04M shares 10-Q · filed 2023-08-11 | 28.08M shares derived: average of 3 quarters · filed 2023-08-11 | 28.06M shares derived: average of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | 28.03M shares 10-Q · filed 2023-05-11 | 28.09M shares derived: average of 2 quarters · filed 2023-05-11 | 28.06M shares derived: average of 3 quarters · filed 2023-05-11 | 22.13M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 28.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 28.08M shares derived: average of 2 quarters · filed 2023-03-30 | 20.16M shares derived: average of 3 quarters · filed 2023-03-30 | 16.09M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 28.01M shares 10-Q · filed 2022-11-14 | 16.17M shares derived: average of 2 quarters · filed 2022-11-14 | 12.07M shares 10-Q · filed 2022-11-14 | 10.06M shares derived: average of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 4.33M shares 10-Q · filed 2022-08-11 | 3.97M shares 10-Q · filed 2022-08-11 | 4.08M shares derived: average of 3 quarters · filed 2022-08-11 | 3.97M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 3.60M shares 10-Q · filed 2022-05-12 | 3.95M shares derived: average of 2 quarters · filed 2022-05-12 | 3.85M shares derived: average of 3 quarters · filed 2022-05-12 | 3.80M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 4.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 3.98M shares derived: average of 2 quarters · filed 2022-03-18 | 3.86M shares derived: average of 3 quarters · filed 2022-03-18 | 3.80M shares 10-K · filed 2022-03-18 |
| 2020-09-30 | 3.65M shares 10-Q · filed 2021-11-12 | 3.64M shares derived: average of 2 quarters · filed 2021-11-12 | 3.63M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 3.64M shares 10-Q · filed 2021-08-13 | 3.64M shares 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |